A Phase I Study of Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 10 Dec 2016
At a glance
- Drugs Pemetrexed (Primary) ; Cisplatin
- Indications Mesothelioma
- Focus Adverse reactions
- 05 Dec 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2016.
- 05 Dec 2016 Status changed from recruiting to withdrawn prior to enrolment due to lack of accrual .
- 11 Jan 2016 New trial record